Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-26-000105

CEO sold 21,164 shares at $2.42 ($51,122)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-11 Sale : show line 1 in the form 10b5-1 −21,164 $2.42 $51,122 265,592 D
Open-market sales · 21,164 sh · avg $2.42 · $51,122
Loading xslF345X06/wk-form4_1794605645.xml…